Mexico Pharmaceuticals Report - Q3 2025
Kaydedildi:
| Yayımlandı: | Fitch Solutions Country Industry Reports (Third Quarter 2025), p. 1 |
|---|---|
| Baskı/Yayın Bilgisi: |
Fitch Solutions Group Limited
|
| Konular: | |
| Online Erişim: | Citation/Abstract Full Text - PDF |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
MARC
| LEADER | 00000nab a2200000uu 4500 | ||
|---|---|---|---|
| 001 | 3202079382 | ||
| 003 | UK-CbPIL | ||
| 022 | |a 2976-4750 | ||
| 035 | |a 3202079382 | ||
| 045 | 2 | |b d20250701 |b d20250930 | |
| 245 | 1 | |a Mexico Pharmaceuticals Report - Q3 2025 | |
| 260 | |b Fitch Solutions Group Limited |c Third Quarter 2025 | ||
| 513 | |a Industry Report | ||
| 520 | 3 | |a Despite facing challenges in drug procurement and patent enforcement, Mexico's pharmaceutical industry is poised for sustained growth, fuelled by an increasing demand for advanced treatments for chronic diseases. As the second largest pharmaceutical market in Latin America, Mexico offers significant opportunities for companies developing innovative medications. Nonetheless, relatively low per capita spending on pharmaceuticals could limit the widespread adoption of patented drugs, potentially boosting the market share of generics. Government initiatives aimed at enhancing local drug manufacturing are expected to foster more international partnerships, particularly in the area of technological exchange. | |
| 651 | 4 | |a Mexico | |
| 653 | |a Pharmaceuticals | ||
| 653 | |a Statistical data | ||
| 653 | |a Industrywide conditions | ||
| 653 | |a Market analysis | ||
| 653 | |a Industry analysis | ||
| 653 | |a Business forecasts | ||
| 653 | |a SWOT analysis | ||
| 653 | |a Pharmaceutical industry | ||
| 773 | 0 | |t Fitch Solutions Country Industry Reports |g (Third Quarter 2025), p. 1 | |
| 786 | 0 | |d ProQuest |t ABI/INFORM Trade & Industry | |
| 856 | 4 | 1 | |3 Citation/Abstract |u https://www.proquest.com/docview/3202079382/abstract/embedded/6A8EOT78XXH2IG52?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text - PDF |u https://www.proquest.com/docview/3202079382/fulltextPDF/embedded/6A8EOT78XXH2IG52?source=fedsrch |